Work

Real-world treatment patterns and outcomes among patients with advanced NSCLC treated with amivantamab.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e20646

Authors: David Michael Waterhouse, Iris Lin, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Yuxi Wang, Lilian Diaz, Patrick Lefebvre, Dexter Waters

Institutions: Oncology Hematology Care, Johnson & Johnson (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Johnson and Johnson

OpenAlex ID: W4410809136

FWCI:

Cites:

Cited by:

Related to: 10